ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 660 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $406,383 | -14.2% | 6,001 | -9.3% | 0.01% | -14.3% |
Q2 2023 | $473,518 | +10.8% | 6,616 | +5.0% | 0.01% | -12.5% |
Q1 2023 | $427,286 | 0.0% | 6,302 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $427,286 | +33.9% | 6,302 | +8.3% | 0.01% | +14.3% |
Q3 2022 | $319,000 | -19.2% | 5,821 | -2.7% | 0.01% | -12.5% |
Q2 2022 | $395,000 | -2.0% | 5,981 | -1.5% | 0.01% | 0.0% |
Q1 2022 | $403,000 | +14.8% | 6,073 | +0.8% | 0.01% | +14.3% |
Q4 2021 | $351,000 | -9.1% | 6,023 | -6.3% | 0.01% | -12.5% |
Q3 2021 | $386,000 | +22.5% | 6,431 | +22.4% | 0.01% | 0.0% |
Q2 2021 | $315,000 | +21.2% | 5,253 | +0.6% | 0.01% | -38.5% |
Q1 2021 | $260,000 | +22.1% | 5,222 | +22.4% | 0.01% | +18.2% |
Q4 2020 | $213,000 | 0.0% | 4,268 | +9.8% | 0.01% | -31.2% |
Q3 2020 | $213,000 | -3.2% | 3,887 | -21.2% | 0.02% | -23.8% |
Q1 2020 | $220,000 | +6.3% | 4,932 | +19.0% | 0.02% | +5.0% |
Q4 2019 | $207,000 | -9.2% | 4,145 | +18.0% | 0.02% | -81.1% |
Q1 2014 | $228,000 | – | 3,512 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |